X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
female (10) 10
index medicus (10) 10
mutation (10) 10
breast cancer (9) 9
history (9) 9
middle aged (9) 9
oncology (9) 9
ovarian cancer (9) 9
aged (8) 8
cancer (8) 8
adult (7) 7
jews (6) 6
cancer therapies (5) 5
chemotherapy (5) 5
holocaust, jewish (5) 5
ovarian neoplasms - drug therapy (5) 5
prospective studies (5) 5
research (5) 5
risk factors (5) 5
tumors (5) 5
womens health (5) 5
analysis (4) 4
antineoplastic agents - therapeutic use (4) 4
clinical medicine (4) 4
diseases (4) 4
drug therapy (4) 4
gene mutations (4) 4
hematology, oncology and palliative medicine (4) 4
holocaust (4) 4
hospitals (4) 4
judenvernichtung (4) 4
neoplasm recurrence, local - drug therapy (4) 4
phthalazines - therapeutic use (4) 4
piperazines - therapeutic use (4) 4
poly polymerase inhibitors (4) 4
relapse (4) 4
therapy (4) 4
world war, 1939-1945 (4) 4
abridged index medicus (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
aufsatzsammlung (3) 3
body mass index (3) 3
brca1 (3) 3
brca1 protein - genetics (3) 3
breast and ovarian analysis of disease incidence and carrier estimation algorithm (3) 3
breast neoplasms - genetics (3) 3
cancer and oncology (3) 3
cancer och onkologi (3) 3
care and treatment (3) 3
catastrophe, jewish (3) 3
christianity (3) 3
clinical trials (3) 3
deoxyribonucleic acid--dna (3) 3
destruction of the jews (3) 3
disease-free survival (3) 3
extermination, jewish (3) 3
familial risk (3) 3
genes, brca1 (3) 3
genes, brca2 (3) 3
germ-line mutation (3) 3
germany (3) 3
health aspects (3) 3
health risk assessment (3) 3
holocaust, nazi (3) 3
internal medicine (3) 3
jewish catastrophe (3) 3
jewish holocaust (3) 3
klinisk medicin (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
medicine, general & internal (3) 3
nazi holocaust (3) 3
nazi persecution (3) 3
nazi persecution of jews (3) 3
oncology, experimental (3) 3
ovarian neoplasms - genetics (3) 3
patients (3) 3
phthalazines - adverse effects (3) 3
piperazines - adverse effects (3) 3
shoah (3) 3
shoʾah (3) 3
studies (3) 3
treatment outcome (3) 3
women (3) 3
young adult (3) 3
ḥurban (3) 3
ḥurbn (3) 3
1933-1945 (2) 2
20th century (2) 2
age factors (2) 2
aide sociale (2) 2
alleles (2) 2
anemia (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
antisemitism (2) 2
atrocities (2) 2
boadicea model (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (11) 11
UTL at Downsview - May be requested (5) 5
Pontifical Inst. Mediaeval Studies - Library use only (4) 4
Victoria University E.J. Pratt - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UofT at Mississauga - Stacks (3) 3
Gerstein Science - Stacks (2) 2
New College (Ivey) - Stacks (2) 2
Regis College - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Baycrest Hospital - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Robarts - Processing (1) 1
St. Augustine's Seminary - Stacks (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University CRRS - Library use only (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (55) 55
German (7) 7
Hebrew (2) 2
Latin (2) 2
Arabic (1) 1
French (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 852 - 861
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10023, pp. 1066 - 1074
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 87 - 97
Summary Background The poly(ADP-ribose) polymerase inhibitor olaparib has shown antitumour activity in patients with platinum-sensitive, recurrent, high-grade... 
Hematology, Oncology and Palliative Medicine | LIPOSOMAL DOXORUBICIN | MULTICENTER | INHIBITION | SOLID TUMORS | CISPLATIN | ONCOLOGY | POLYMERASE | OPEN-LABEL | COMBINATION | CARCINOMA | MAINTENANCE THERAPY | Piperazines - administration & dosage | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - administration & dosage | Ovarian Neoplasms - mortality | Molecular Targeted Therapy | Enzyme Inhibitors - administration & dosage | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Time Factors | Antineoplastic Agents - adverse effects | Adult | Female | Neoplasms, Cystic, Mucinous, and Serous - drug therapy | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Enzyme Inhibitors - adverse effects | Neoplasms, Cystic, Mucinous, and Serous - pathology | Phthalazines - administration & dosage | Drug Administration Schedule | Administration, Oral | Neoplasm Recurrence, Local | Carboplatin - administration & dosage | Neoplasms, Cystic, Mucinous, and Serous - enzymology | Treatment Outcome | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors | Ovarian Neoplasms - enzymology | BRCA1 Protein - genetics | Disease-Free Survival | Administration, Intravenous | Poly(ADP-ribose) Polymerases - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Mutation | BRCA2 Protein - genetics | Neoplasms, Cystic, Mucinous, and Serous - mortality | Phthalazines - adverse effects | Relapse | Chemotherapy | Hospitals | Gene mutations | Sugars | Diseases | Cancer | Monosaccharides | Ovarian cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1579 - 1589
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9737, pp. 245 - 251
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9737, pp. 235 - 244
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2019, Volume 20, Issue 9, pp. 1306 - 1315
SummaryBackgroundRationale exists for combined treatment with immune checkpoint inhibitors and poly (ADP-ribose) polymerase (PARP) inhibitors in a variety of... 
Hematology, Oncology, and Palliative Medicine | TOXICITIES | ONCOLOGY | CLINICAL-TRIALS | MUTATIONAL LANDSCAPE | SENSITIVITY | CANCER | EXPRESSION | Monoclonal antibodies | Analysis | Sugars | Monosaccharides
Journal Article
1998, 1st ed., ISBN 9780412792908, xvi, 373
Book
Journal Article
ISSN 1465-5411, 2018
Background: The association between body mass index (BMI) and risk of breast cancer depends on time of life, but it is unknown whether this association depends... 
kConFab Investigators
Journal Article